Dr. Cooperberg on Ongoing Trials in Early Prostate Cancer

Matthew R. Cooperberg, MD, MPH
Published: Tuesday, Oct 31, 2017



Matthew R. Cooperberg, MD, MPH, an associate professor of urology, epidemiology, and biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (USCF), discusses ongoing trials in early prostate cancer.

There are several ongoing trials looking at adjuvant versus early salvage radiation therapy. Three trials that have already been published support the use of secondary radiation therapy after surgery for men with adverse pathology.

However, these trials do not determine if secondary radiation needs to be given in the adjuvant or early salvage setting, says Cooperberg.

There are also ongoing trials looking at cytoreduction for metastatic disease, explains Cooperberg.


Matthew R. Cooperberg, MD, MPH, an associate professor of urology, epidemiology, and biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (USCF), discusses ongoing trials in early prostate cancer.

There are several ongoing trials looking at adjuvant versus early salvage radiation therapy. Three trials that have already been published support the use of secondary radiation therapy after surgery for men with adverse pathology.

However, these trials do not determine if secondary radiation needs to be given in the adjuvant or early salvage setting, says Cooperberg.

There are also ongoing trials looking at cytoreduction for metastatic disease, explains Cooperberg.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x